The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) FCF Margin %: 0.00% (As of . 20)


DHA:IBNSINA The IBN SINA Pharmaceutical Industry PLC DHA:IBNSINA
20 GF Score
Price BDT318.20
View Full Analysis

What is The IBN SINA Pharmaceutical Industry FCF Margin %?

The IBN SINA Pharmaceutical Industry DHA:IBNSINA +0.47% 20 FCF Margin % is 0.00% as of . 20. GuruFocus rates DHA:IBNSINA with a GF Score™ of 20/100. Among 958 Drug Manufacturers companies, The IBN SINA Pharmaceutical Industry ranks worse than 104384.03% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. The IBN SINA Pharmaceutical Industry's Free Cash Flow for the six months ended in . 20 was BDT0.00 Mil. The IBN SINA Pharmaceutical Industry's Revenue for the six months ended in . 20 was BDT0.00 Mil. Therefore, The IBN SINA Pharmaceutical Industry's FCF Margin % for the quarter that ended in . 20 was 0.00%.

As of today, The IBN SINA Pharmaceutical Industry's current FCF Yield % is 0.00%.

The historical rank and industry rank for The IBN SINA Pharmaceutical Industry's FCF Margin % or its related term are showing as below:


DHA:IBNSINA's FCF Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.445
* Ranked among companies with meaningful FCF Margin % only.

The IBN SINA Pharmaceutical Industry FCF Margin % Related Terms

The IBN SINA Pharmaceutical Industry FCF Margin % Historical Data

* Premium members only.

The historical data trend for The IBN SINA Pharmaceutical Industry's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The IBN SINA Pharmaceutical Industry FCF Margin % Chart

The IBN SINA Pharmaceutical Industry Annual Data
Trend
FCF Margin %

The IBN SINA Pharmaceutical Industry Semi-Annual Data
FCF Margin %

DHA:IBNSINA vs IMNPQ: FCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, The IBN SINA Pharmaceutical Industry's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

The IBN SINA Pharmaceutical Industry FCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, The IBN SINA Pharmaceutical Industry's FCF Margin % distribution charts can be found below:

* The bar in red indicates where The IBN SINA Pharmaceutical Industry's FCF Margin % falls into.


DHA:IBNSINA
20GF Score
The IBN SINA Pharmaceutical Industry PLC DHA:IBNSINA
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The IBN SINA Pharmaceutical Industry FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

The IBN SINA Pharmaceutical Industry's FCF Margin for the fiscal year that ended in . 20 is calculated as

FCF Margin=Free Cash Flow (A: . 20 )/Revenue (A: . 20 )
=/
= %

The IBN SINA Pharmaceutical Industry's FCF Margin for the quarter that ended in . 20 is calculated as

FCF Margin=Free Cash Flow (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) has a FCF Margin % of 0.00% as of . 20. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on The IBN SINA Pharmaceutical Industry and its competitors. According to the industry distribution chart, The IBN SINA Pharmaceutical Industry ranks #999999 out of 958 companies in the Drug Manufacturers industry.
Is The IBN SINA Pharmaceutical Industry's FCF Margin % too high?
The IBN SINA Pharmaceutical Industry's current FCF Margin % is 0.00%. Based on the distribution chart, The IBN SINA Pharmaceutical Industry ranks #999999 out of 958 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, The IBN SINA Pharmaceutical Industry has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does The IBN SINA Pharmaceutical Industry's FCF Margin % compare to IMNPQ?
According to the Drug Manufacturers industry distribution chart, The IBN SINA Pharmaceutical Industry ranks #999999 out of 958 companies for FCF Margin %. This places The IBN SINA Pharmaceutical Industry in the lower half of its industry. The industry median FCF Margin % is 2.45. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.45, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on The IBN SINA Pharmaceutical Industry and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The IBN SINA Pharmaceutical Industry's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The IBN SINA Pharmaceutical Industry stock overvalued right now?
The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. The IBN SINA Pharmaceutical Industry's overall GF Score™ is 20/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For The IBN SINA Pharmaceutical Industry (DHA:IBNSINA), the current FCF Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The IBN SINA Pharmaceutical Industry Business Description

Address Mirpur Road, Tanin Center, 3 Asad Gate, Mohammadpur, Dhaka, BGD, 1207
The IBN SINA Pharmaceutical Industry PLC is engaged in the production and marketing of pharmaceutical drugs and natural medicines in both the local and international market.
20GF Score

Get the complete analysis for DHA:IBNSINA

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT318.20
Price